Selective Serotonin Reuptake Inhibitors for Stroke Recovery: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OutcomesThe primary outcomes were dependence and disability.The secondary outcomes were neurological impairments, depression, anxiety, quality of life, fatigue, healthcare cost, death, leaving the trial early, death, and adverse events including gastrointestinal side effects, bleeding, and seizures. Risk of BiasThe Cochrane Collaboration's risk of bias tool assessed risk of bias in relation to randomization, allocation concealment, blinding, incomplete outcome data, and selective reporting.5 A Funnel plot assessed publication bias. Synthesis of ResultsFor trials with a control arm and 2 active arms, data from the control arm and the SSRI arm were included.Review Manager (RevMan 5.1) software 6 calculated summary statistics at the end of intervention and at the end of follow-up.Statistical heterogeneity between trials and subgroups was assessed by I 2 statistic and interpreted according to The Cochrane Handbook.5 Summary MeasuresRandom effects meta-analyses were performed, using risk ratios (RRs) for dichotomous data and for ordinal scales with a recognized cut point.Standardized mean difference (SMD) was used for ordinal scales and continuous data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70314-8 · Cited by 925 · cited 3×
“Sensitivity analyses for dependence could not be performed because there was only 1 trial.(2) For trials at low risk of bias for each of randomization, allocation concealment, patient/per-”
BackgroundInterventions for treating depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub3 · Cited by 387
Self-citationAcler, M., Robol, E., Fiaschi, A., & Manganotti, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5093-7 · Cited by 139
Cited by
Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Post-stroke depression: A 2020 updated review
Medeiros, G. C., Roy, D., Kontos, N., & Beach, S. R. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.011 · Cited by 587
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 532
The interaction between training and plasticity in the poststroke brain
Zeiler, S. R., & Krakauer, J. W. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000025 · Cited by 402
The advances of post-stroke depression: 2021 update
Guo, J., Wang, J., Sun, W., & Liu, X. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10597-4 · Cited by 400
Baker, C., Worrall, L., Rose, M., Hudson, K., Ryan, B., & O’Byrne, L. (2018) · Disability and Rehabilitation · doi:10.1080/09638288.2017.1315181 · Cited by 186
“Further, a recent comprehensive review of pharmacological interventions in stroke recovery is available [34].”
BackgroundNew Evidence for Therapies in Stroke Rehabilitation
Dobkin, B. H., & Dorsch, A. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0331-y · Cited by 146
“This work needs to be replicated [87].”
Li, Y., Li, H.-P., Wu, M.-X., Wang, Q.-Y., & Zeng, X. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.07.369 · Cited by 19
Metadata
- Authors
- Mead, G. E., Hsieh, C.-F., Lee, R., Kutlubaev, M., Claxton, A., Hankey, G. J., & Hackett, M.
- Venue
- Stroke
- Published
- 2013-03
- Volume
- 44
- Issue
- 3
- Pages
- 844-850
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2011628604
- Cited by
- 106
- References
- 3
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.